JENNIFER KOETJE: Open Payments
NPI 1912908997 · WHITEHALL, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 42 payments from 8 companies in 2025. Trend: 2023 $36 · 2024 $657 · 2025 $850
Food & beverage: $850
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $203 |
| AstraZeneca Pharmaceuticals LP | 11 | $199 |
| Novo Nordisk Inc | 10 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| ABBVIE INC. | 3 | $73 |
| Exact Sciences Corporation | 3 | $71 |
| PFIZER INC. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: AIRSUPRA, ZEPBOUND, Saxenda, CAPLYTA, MOUNJARO, Ozempic, QULIPTA, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
